~~<i id='F5E54B1A7A'><strike id='F5E54B1A7A'><tt id='F5E54B1A7A'><pre id='F5E54B1A7A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

author：explore 2025-10-01 01:50:03 - browse：454

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Medical school prerequisites are outdated

hotspot

focus

knowledge

hotspot

focus

knowledge

MollyFergusonforSTATSTATnowpublishesselectedLetterstotheEditorreceivedinresponsetoFirstOpinionessays

WSS

Alabama hospital puts IVF treatments on hold

Obesity drugs seen as possible treatment for liver disease MASH

UnitedHealth sued over use of algorithm in Medicare Advantage plans

He's a Nobel laureate. Critics say he was misleading on Covid

Study suggests Covid rebound is far more common with Paxlovid than without

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

explore

explore

hotspot

Supreme Court strikes down use of affirmative action

Community Health Systems hospitals under DOJ investigation

Sports medicine is finally prioritizing gender equality

Alabama frozen embryo ruling has major implications for IVF clinics

At least 13 dead in Texas as scorching temps continue

NIH study of ME/CFS points to clear biological hallmarks

United colonoscopy coverage change 'may cost lives,' doctors say

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Walensky prepares to leave CDC — and Congress — behind

In utero gene editing: an explainer

focus

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Cancer diagnosis changes perspective doctor, former hospital CEO

CVS, Rite Aid closures threaten to worsen pharmacy deserts

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Today's health inequities arise from racist U.S. history, say experts

knowledge

hotspot

focus

knowledge